CAR T-cell Therapy Market Report

1 Report Overview

• 1.1 Product Definition and Scope

• 1.2 PEST (Political, Economic, Social and Technological) Analysis of CAR T-cell Therapy Market

• 1.3 Market Segment by Type

• 1.3.1 Japan CAR T-cell Therapy Market Size and Growth Rate of CD 19 from 2014 to 2026

• 1.3.2 Japan CAR T-cell Therapy Market Size and Growth Rate of CD 20 from 2014 to 2026

• 1.3.3 Japan CAR T-cell Therapy Market Size and Growth Rate of CD22 from 2014 to 2026

• 1.3.4 Japan CAR T-cell Therapy Market Size and Growth Rate of CD30 from 2014 to 2026

• 1.3.5 Japan CAR T-cell Therapy Market Size and Growth Rate of CD33 from 2014 to 2026

• 1.3.6 Japan CAR T-cell Therapy Market Size and Growth Rate of HER1 from 2014 to 2026

• 1.3.7 Japan CAR T-cell Therapy Market Size and Growth Rate of HER2 from 2014 to 2026

• 1.3.8 Japan CAR T-cell Therapy Market Size and Growth Rate of Meso from 2014 to 2026

• 1.3.9 Japan CAR T-cell Therapy Market Size and Growth Rate of Egfrvlll from 2014 to 2026

• 1.4 Market Segment by Application

• 1.4.1 Japan CAR T-cell Therapy Market Size and Growth Rate of Acute Lymphocytic Leukemia from 2014 to 2026

• 1.4.2 Japan CAR T-cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2014 to 2026

• 1.4.3 Japan CAR T-cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia from 2014 to 2026

• 1.4.4 Japan CAR T-cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

• 1.4.5 Japan CAR T-cell Therapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

• 1.5 Market Segment by Regions

• 1.5.1 Hokkaido CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.2 Tohoku CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.3 Kanto CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.4 Chubu CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.5 Kinki CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.6 Chugoku CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.7 Shikoku CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• 1.5.8 Kyushu CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

• 2.1 Market Trends and Dynamics

• 2.1.1 Market Challenges and Restraints

• 2.1.2 Market Opportunities and Potentials

• 2.1.3 Mergers and Acquisitions

• 2.2 Competitive Landscape Analysis

• 2.2.1 Industrial Concentration Analysis

• 2.2.2 Porter's Five Forces Analysis of the Industry

• 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of CAR T-cell Therapy Market by Types

• 3.1 Products Development Trends of Different Types

• 3.2 Commercial Products Types of Major Vendors

• 3.3 Competitive Landscape Analysis of Different Types

• 3.4 Market Size of CAR T-cell Therapy by Major Types

• 3.4.1 Market Size and Growth Rate of CD 19

• 3.4.2 Market Size and Growth Rate of CD 20

• 3.4.3 Market Size and Growth Rate of CD22

• 3.4.4 Market Size and Growth Rate of CD30

• 3.4.5 Market Size and Growth Rate of CD33

• 3.4.6 Market Size and Growth Rate of HER1

• 3.4.7 Market Size and Growth Rate of HER2

• 3.4.8 Market Size and Growth Rate of Meso

• 3.4.9 Market Size and Growth Rate of Egfrvlll

4 Segmentation of CAR T-cell Therapy Market by End-Users

• 4.1 Downstream Client Analysis by End-Users

• 4.2 Competitive Landscape Analysis of Different End-Users

• 4.3 Market Potential Analysis of Different End-Users

• 4.4 Market Size of CAR T-cell Therapy by Major End-Users

• 4.4.1 Market Size and Growth Rate of CAR T-cell Therapy in Acute Lymphocytic Leukemia

• 4.4.2 Market Size and Growth Rate of CAR T-cell Therapy in Chronic Lymphocytic Leukemia

• 4.4.3 Market Size and Growth Rate of CAR T-cell Therapy in Non Hodgkin Leukemia

• 4.4.4 Market Size and Growth Rate of CAR T-cell Therapy in Multiple Myeloma

• 4.4.5 Market Size and Growth Rate of CAR T-cell Therapy in Pancreatic Cancer

5 Market Analysis by Regions

• 5.1 Japan CAR T-cell Therapy Production Analysis by Regions

• 5.2 Japan CAR T-cell Therapy Consumption Analysis by Regions

6 Hokkaido CAR T-cell Therapy Landscape Analysis

• 6.1 Hokkaido CAR T-cell Therapy Landscape Analysis by Major Types

• 6.2 Hokkaido CAR T-cell Therapy Landscape Analysis by Major End-Users

7 Tohoku CAR T-cell Therapy Landscape Analysis

• 7.1 Tohoku CAR T-cell Therapy Landscape Analysis by Major Types

• 7.2 Tohoku CAR T-cell Therapy Landscape Analysis by Major End-Users

8 Kanto CAR T-cell Therapy Landscape Analysis

• 8.1 Kanto CAR T-cell Therapy Landscape Analysis by Major Types

• 8.2 Kanto CAR T-cell Therapy Landscape Analysis by Major End-Users

9 Chubu CAR T-cell Therapy Landscape Analysis

• 9.1 Chubu CAR T-cell Therapy Landscape Analysis by Major Types

• 9.2 Chubu CAR T-cell Therapy Landscape Analysis by Major End-Users

10 Kinki CAR T-cell Therapy Landscape Analysis

• 10.1 Kinki CAR T-cell Therapy Landscape Analysis by Major Types

• 10.2 Kinki CAR T-cell Therapy Landscape Analysis by Major End-Users

11 Chugoku CAR T-cell Therapy Landscape Analysis

• 11.1 Chugoku CAR T-cell Therapy Landscape Analysis by Major Types

• 11.2 Chugoku CAR T-cell Therapy Landscape Analysis by Major End-Users

12 Shikoku CAR T-cell Therapy Landscape Analysis

• 12.1 Shikoku CAR T-cell Therapy Landscape Analysis by Major Types

• 12.2 Shikoku CAR T-cell Therapy Landscape Analysis by Major End-Users

13 Kyushu CAR T-cell Therapy Landscape Analysis

• 13.1 Kyushu CAR T-cell Therapy Landscape Analysis by Major Types

• 13.2 Kyushu CAR T-cell Therapy Landscape Analysis by Major End-Users

14 Major Players Profiles

• 14.1 Novartis, Inc.
  

• 14.1.1 Novartis, Inc. Company Profile and Recent Development

• 14.1.2 Market Performance

• 14.1.3 Product and Service Introduction

• 14.2 CARsgen Therapeutics, Ltd.
  

• 14.2.1 CARsgen Therapeutics, Ltd. Company Profile and Recent Development

• 14.2.2 Market Performance

• 14.2.3 Product and Service Introduction

• 14.3 Aurora Biopharma Inc.
  

• 14.3.1 Aurora Biopharma Inc. Company Profile and Recent Development

• 14.3.2 Market Performance

• 14.3.3 Product and Service Introduction

• 14.4 Allogene Therapeutics, Inc.
  

• 14.4.1 Allogene Therapeutics, Inc. Company Profile and Recent Development

• 14.4.2 Market Performance

• 14.4.3 Product and Service Introduction

• 14.5 Legend Biotech
  

• 14.5.1 Legend Biotech Company Profile and Recent Development

• 14.5.2 Market Performance

• 14.5.3 Product and Service Introduction

• 14.6 Bluebird Bio, Inc.
  

• 14.6.1 Bluebird Bio, Inc. Company Profile and Recent Development

• 14.6.2 Market Performance

• 14.6.3 Product and Service Introduction

• 14.7 Kite Pharma, Inc.
  

• 14.7.1 Kite Pharma, Inc. Company Profile and Recent Development

• 14.7.2 Market Performance

• 14.7.3 Product and Service Introduction

• 14.8 Aurora BioPharma International AGech
  

• 14.8.1 Aurora BioPharma International AGech Company Profile and Recent Development

• 14.8.2 Market Performance

• 14.8.3 Product and Service Introduction

• 14.9 Celgene (Juno Therapeutics) Inc.
  

• 14.9.1 Celgene (Juno Therapeutics) Inc. Company Profile and Recent Development

• 14.9.2 Market Performance

• 14.9.3 Product and Service Introduction

• 14.10 Juno Therapeutics
  

• 14.10.1 Juno Therapeutics Company Profile and Recent Development

• 14.10.2 Market Performance

• 14.10.3 Product and Service Introduction

• 14.11 Bluebird Bio, Inc.
  

• 14.11.1 Bluebird Bio, Inc. Company Profile and Recent Development

• 14.11.2 Market Performance

• 14.11.3 Product and Service Introduction

• 14.12 CARsgen Therapeutics, Ltd.
  

• 14.12.1 CARsgen Therapeutics, Ltd. Company Profile and Recent Development

• 14.12.2 Market Performance

• 14.12.3 Product and Service Introduction

The List of Tables and Figures (Totals 126 Figures and 190 Tables)

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of CD 19 from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of CD 20 from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of CD22 from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of CD30 from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of CD33 from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of HER1 from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of HER2 from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Meso from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Egfrvlll from 2014 to 2026

• Figure Market Share by Type in 2014

• Figure Market Share by Type in 2018

• Figure Market Share by Type in 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Acute Lymphocytic Leukemia from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

• Figure Market Share by End-User in 2014

• Figure Market Share by End-User in 2018

• Figure Market Share by End-User in 2026

• Figure Hokkaido CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Tohoku CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kanto CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Chubu CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kinki CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Chugoku CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Shikoku CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Kyushu CAR T-cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Development Trends and Industry Dynamics of CAR T-cell Therapy Industry

• Figure Market Challenges and Restraints

• Figure Market Opportunities and Potentials

• Table Mergers and Acquisition

• Figure Market Share of TOP 3 Players in 2018

• Figure Market Share of TOP 5 Players in 2018

• Figure Market Share of TOP 6 Players from 2014 to 2019

• Figure Porter's Five Forces Analysis

• Figure New Entrant SWOT Analysis

• Table Specifications of Different Types of CAR T-cell Therapy

• Figure Development Trends of Different Types

• Table Commercial Products Types of Major Vendors

• Figure Competitive Landscape Analysis of Different Types

• Table Consumption of CAR T-cell Therapy by Different Types from 2014 to 2026

• Table Consumption Share of CAR T-cell Therapy by Different Types from 2014 to 2026

• Figure Market Size and Growth Rate of CD 19

• Figure Market Size and Growth Rate of CD 20

• Figure Market Size and Growth Rate of CD22

• Figure Market Size and Growth Rate of CD30

• Figure Market Size and Growth Rate of CD33

• Figure Market Size and Growth Rate of HER1

• Figure Market Size and Growth Rate of HER2

• Figure Market Size and Growth Rate of Meso

• Figure Market Size and Growth Rate of Egfrvlll

• Table Downstream Client Analysis by End-Users

• Figure Competitive Landscape Analysis of Different End-Users

• Table Market Potential Analysis of Different End-Users

• Table Consumption of CAR T-cell Therapy by Different End-Users from 2014 to 2026

• Table Consumption Share of CAR T-cell Therapy by Different End-Users from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Acute Lymphocytic Leukemia from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Chronic Lymphocytic Leukemia from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Non Hodgkin Leukemia from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

• Figure Japan CAR T-cell Therapy Market Size and Growth Rate of Pancreatic Cancer from 2014 to 2026

• Table Japan CAR T-cell Therapy Production by Regions

• Table Japan CAR T-cell Therapy Production Share by Regions

• Figure Japan CAR T-cell Therapy Production Share by Regions in 2014

• Figure Japan CAR T-cell Therapy Production Share by Regions in 2018

• Figure Japan CAR T-cell Therapy Production Share by Regions in 2026

• Table Japan CAR T-cell Therapy Consumption by Regions

• Table Japan CAR T-cell Therapy Consumption Share by Regions

• Figure Japan CAR T-cell Therapy Consumption Share by Regions in 2014

• Figure Japan CAR T-cell Therapy Consumption Share by Regions in 2018

• Figure Japan CAR T-cell Therapy Consumption Share by Regions in 2026

• Table Hokkaido CAR T-cell Therapy Consumption by Types from 2014 to 2026

• Table Hokkaido CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Hokkaido CAR T-cell Therapy Consumption Share by Types in 2014

• Figure Hokkaido CAR T-cell Therapy Consumption Share by Types in 2018

• Figure Hokkaido CAR T-cell Therapy Consumption Share by Types in 2026

• Table Hokkaido CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

• Table Hokkaido CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Hokkaido CAR T-cell Therapy Consumption Share by End-Users in 2014

• Figure Hokkaido CAR T-cell Therapy Consumption Share by End-Users in 2018

• Figure Hokkaido CAR T-cell Therapy Consumption Share by End-Users in 2026

• Table Tohoku CAR T-cell Therapy Consumption by Types from 2014 to 2026

• Table Tohoku CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Tohoku CAR T-cell Therapy Consumption Share by Types in 2014

• Figure Tohoku CAR T-cell Therapy Consumption Share by Types in 2018

• Figure Tohoku CAR T-cell Therapy Consumption Share by Types in 2026

• Table Tohoku CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

• Table Tohoku CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Tohoku CAR T-cell Therapy Consumption Share by End-Users in 2014

• Figure Tohoku CAR T-cell Therapy Consumption Share by End-Users in 2018

• Figure Tohoku CAR T-cell Therapy Consumption Share by End-Users in 2026

• Table Kanto CAR T-cell Therapy Consumption by Types from 2014 to 2026

• Table Kanto CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Kanto CAR T-cell Therapy Consumption Share by Types in 2014

• Figure Kanto CAR T-cell Therapy Consumption Share by Types in 2018

• Figure Kanto CAR T-cell Therapy Consumption Share by Types in 2026

• Table Kanto CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

• Table Kanto CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Kanto CAR T-cell Therapy Consumption Share by End-Users in 2014

• Figure Kanto CAR T-cell Therapy Consumption Share by End-Users in 2018

• Figure Kanto CAR T-cell Therapy Consumption Share by End-Users in 2026

• Table Chubu CAR T-cell Therapy Consumption by Types from 2014 to 2026

• Table Chubu CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Chubu CAR T-cell Therapy Consumption Share by Types in 2014

• Figure Chubu CAR T-cell Therapy Consumption Share by Types in 2018

• Figure Chubu CAR T-cell Therapy Consumption Share by Types in 2026

• Table Chubu CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

• Table Chubu CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Chubu CAR T-cell Therapy Consumption Share by End-Users in 2014

• Figure Chubu CAR T-cell Therapy Consumption Share by End-Users in 2018

• Figure Chubu CAR T-cell Therapy Consumption Share by End-Users in 2026

• Table Kinki CAR T-cell Therapy Consumption by Types from 2014 to 2026

• Table Kinki CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Kinki CAR T-cell Therapy Consumption Share by Types in 2014

• Figure Kinki CAR T-cell Therapy Consumption Share by Types in 2018

• Figure Kinki CAR T-cell Therapy Consumption Share by Types in 2026

• Table Kinki CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

• Table Kinki CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Kinki CAR T-cell Therapy Consumption Share by End-Users in 2014

• Figure Kinki CAR T-cell Therapy Consumption Share by End-Users in 2018

• Figure Kinki CAR T-cell Therapy Consumption Share by End-Users in 2026

• Table Chugoku CAR T-cell Therapy Consumption by Types from 2014 to 2026

• Table Chugoku CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Chugoku CAR T-cell Therapy Consumption Share by Types in 2014

• Figure Chugoku CAR T-cell Therapy Consumption Share by Types in 2018

• Figure Chugoku CAR T-cell Therapy Consumption Share by Types in 2026

• Table Chugoku CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

• Table Chugoku CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Chugoku CAR T-cell Therapy Consumption Share by End-Users in 2014

• Figure Chugoku CAR T-cell Therapy Consumption Share by End-Users in 2018

• Figure Chugoku CAR T-cell Therapy Consumption Share by End-Users in 2026

• Table Shikoku CAR T-cell Therapy Consumption by Types from 2014 to 2026

• Table Shikoku CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Shikoku CAR T-cell Therapy Consumption Share by Types in 2014

• Figure Shikoku CAR T-cell Therapy Consumption Share by Types in 2018

• Figure Shikoku CAR T-cell Therapy Consumption Share by Types in 2026

• Table Shikoku CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

• Table Shikoku CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Shikoku CAR T-cell Therapy Consumption Share by End-Users in 2014

• Figure Shikoku CAR T-cell Therapy Consumption Share by End-Users in 2018

• Figure Shikoku CAR T-cell Therapy Consumption Share by End-Users in 2026

• Table Kyushu CAR T-cell Therapy Consumption by Types from 2014 to 2026

• Table Kyushu CAR T-cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Kyushu CAR T-cell Therapy Consumption Share by Types in 2014

• Figure Kyushu CAR T-cell Therapy Consumption Share by Types in 2018

• Figure Kyushu CAR T-cell Therapy Consumption Share by Types in 2026

• Table Kyushu CAR T-cell Therapy Consumption by End-Users from 2014 to 2026

• Table Kyushu CAR T-cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Kyushu CAR T-cell Therapy Consumption Share by End-Users in 2014

• Figure Kyushu CAR T-cell Therapy Consumption Share by End-Users in 2018

• Figure Kyushu CAR T-cell Therapy Consumption Share by End-Users in 2026

• Table Company Profile and Development Status of Novartis, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis, Inc.

• Figure Sales and Growth Rate Analysis of Novartis, Inc.

• Figure Revenue and Market Share Analysis of Novartis, Inc.

• Table Product and Service Introduction of Novartis, Inc.

• Table Company Profile and Development Status of CARsgen Therapeutics, Ltd.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of CARsgen Therapeutics, Ltd.

• Figure Sales and Growth Rate Analysis of CARsgen Therapeutics, Ltd.

• Figure Revenue and Market Share Analysis of CARsgen Therapeutics, Ltd.

• Table Product and Service Introduction of CARsgen Therapeutics, Ltd.

• Table Company Profile and Development Status of Aurora Biopharma Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurora Biopharma Inc.

• Figure Sales and Growth Rate Analysis of Aurora Biopharma Inc.

• Figure Revenue and Market Share Analysis of Aurora Biopharma Inc.

• Table Product and Service Introduction of Aurora Biopharma Inc.

• Table Company Profile and Development Status of Allogene Therapeutics, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allogene Therapeutics, Inc.

• Figure Sales and Growth Rate Analysis of Allogene Therapeutics, Inc.

• Figure Revenue and Market Share Analysis of Allogene Therapeutics, Inc.

• Table Product and Service Introduction of Allogene Therapeutics, Inc.

• Table Company Profile and Development Status of Legend Biotech

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Legend Biotech

• Figure Sales and Growth Rate Analysis of Legend Biotech

• Figure Revenue and Market Share Analysis of Legend Biotech

• Table Product and Service Introduction of Legend Biotech

• Table Company Profile and Development Status of Bluebird Bio, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio, Inc.

• Figure Sales and Growth Rate Analysis of Bluebird Bio, Inc.

• Figure Revenue and Market Share Analysis of Bluebird Bio, Inc.

• Table Product and Service Introduction of Bluebird Bio, Inc.

• Table Company Profile and Development Status of Kite Pharma, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma, Inc.

• Figure Sales and Growth Rate Analysis of Kite Pharma, Inc.

• Figure Revenue and Market Share Analysis of Kite Pharma, Inc.

• Table Product and Service Introduction of Kite Pharma, Inc.

• Table Company Profile and Development Status of Aurora BioPharma International AGech

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurora BioPharma International AGech

• Figure Sales and Growth Rate Analysis of Aurora BioPharma International AGech

• Figure Revenue and Market Share Analysis of Aurora BioPharma International AGech

• Table Product and Service Introduction of Aurora BioPharma International AGech

• Table Company Profile and Development Status of Celgene (Juno Therapeutics) Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene (Juno Therapeutics) Inc.

• Figure Sales and Growth Rate Analysis of Celgene (Juno Therapeutics) Inc.

• Figure Revenue and Market Share Analysis of Celgene (Juno Therapeutics) Inc.

• Table Product and Service Introduction of Celgene (Juno Therapeutics) Inc.

• Table Company Profile and Development Status of Juno Therapeutics

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics

• Figure Sales and Growth Rate Analysis of Juno Therapeutics

• Figure Revenue and Market Share Analysis of Juno Therapeutics

• Table Product and Service Introduction of Juno Therapeutics

• Table Company Profile and Development Status of Bluebird Bio, Inc.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio, Inc.

• Figure Sales and Growth Rate Analysis of Bluebird Bio, Inc.

• Figure Revenue and Market Share Analysis of Bluebird Bio, Inc.

• Table Product and Service Introduction of Bluebird Bio, Inc.

• Table Company Profile and Development Status of CARsgen Therapeutics, Ltd.

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of CARsgen Therapeutics, Ltd.

• Figure Sales and Growth Rate Analysis of CARsgen Therapeutics, Ltd.

• Figure Revenue and Market Share Analysis of CARsgen Therapeutics, Ltd.

• Table Product and Service Introduction of CARsgen Therapeutics, Ltd.